Article
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of…
bioRxiv · 2021 · Tirosh Shapira
Key facts
| Title | A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice |
|---|---|
| First author | Tirosh Shapira |
| Journal | bioRxiv |
| Published | May 4, 2021 |
| DOI | 10.1101/2021.05.03.442520 |
| Devices mentioned | K040782, K042152, K940422, K982100 |
| Product codes mentioned | CFN, DFZ, JAK, JQC, NNL |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1